Role of ionizing radiation activated NRF2 in lung cancer radioresistance.

[1]  G. Wang,et al.  Current Nano-Strategies to Improve Therapeutic Efficacy Across Special Structures , 2022, OpenNano.

[2]  G. Wang,et al.  Tailoring radiotherapies and nanotechnology for targeted treatment of solid tumors , 2022, Coordination Chemistry Reviews.

[3]  R. Cowell,et al.  The NRF2-Dependent Transcriptional Regulation of Antioxidant Defense Pathways: Relevance for Cell Type-Specific Vulnerability to Neurodegeneration and Therapeutic Intervention , 2021, Antioxidants.

[4]  Yaoyan Dun,et al.  The dynamic changes of Nrf2 mediated oxidative stress, DNA damage and base excision repair in testis of rats during aging , 2021, Experimental Gerontology.

[5]  K. Tew,et al.  Nrf2 inhibition sensitizes breast cancer stem cells to ionizing radiation via suppressing DNA repair. , 2021, Free radical biology & medicine.

[6]  B. Qiu,et al.  Role of receptor tyrosine kinases mediated signal transduction pathways in tumor growth and angiogenesis-New insight and futuristic vision. , 2021, International journal of biological macromolecules.

[7]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[8]  Wei Zhang,et al.  LncRNA linc00312 suppresses radiotherapy resistance by targeting DNA-PKcs and impairing DNA damage repair in nasopharyngeal carcinoma , 2021, Cell death & disease.

[9]  Hafiz M.N. Iqbal,et al.  Tyrosine kinase inhibitors and their unique therapeutic potentialities to combat cancer. , 2020, International journal of biological macromolecules.

[10]  R. Zhuang,et al.  Nrf2 Mediates Metabolic Reprogramming in Non-Small Cell Lung Cancer , 2020, Frontiers in Oncology.

[11]  Sara Sofia Deville,et al.  Keap1 inhibition sensitizes head and neck squamous cell carcinoma cells to ionizing radiation via impaired non-homologous end joining and induced autophagy , 2020, Cell Death & Disease.

[12]  B. Qiu,et al.  New insights on unique therapeutic potentialities of prostacyclin and prostacyclin synthase , 2020 .

[13]  A. Venkitaraman,et al.  Pulsatile MAPK Signaling Modulates p53 Activity to Control Cell Fate Decisions at the G2 Checkpoint for DNA Damage , 2020, Cell reports.

[14]  Bin Liu,et al.  Automobile exhaust-derived PM2.5 induces blood-testis barrier damage through ROS-MAPK-Nrf2 pathway in sertoli cells of rats. , 2019, Ecotoxicology and environmental safety.

[15]  A. Jeyasekharan,et al.  ROS and the DNA damage response in cancer , 2018, Redox biology.

[16]  K. Khanna,et al.  RAD51 paralogs promote genomic integrity and chemoresistance in cancer by facilitating homologous recombination. , 2018, Annals of translational medicine.

[17]  Brent D. Cameron,et al.  The Role of Nrf2 in the Response to Normal Tissue Radiation Injury , 2018, Radiation Research.

[18]  H. Motohashi,et al.  NRF2 addiction in cancer cells , 2018, Cancer science.

[19]  D. Tuveson,et al.  Transcriptional Regulation by Nrf2 , 2017, Antioxidants & redox signaling.

[20]  Masayuki Yamamoto,et al.  The KEAP1–NRF2 System in Cancer , 2017, Front. Oncol..

[21]  Brandon Da Silva,et al.  NRF2 Promotes Tumor Maintenance by Modulating mRNA Translation in Pancreatic Cancer , 2016, Cell.

[22]  W. Greenhalf,et al.  UHRF1 regulation of the Keap1–Nrf2 pathway in pancreatic cancer contributes to oncogenesis , 2015, The Journal of pathology.

[23]  David M Jablons,et al.  Lung Cancer Staging and Prognosis. , 2016, Cancer treatment and research.

[24]  Debojyoti Pal,et al.  Nrf2 facilitates repair of radiation induced DNA damage through homologous recombination repair pathway in a ROS independent manner in cancer cells. , 2015, Mutation research.

[25]  G. Giaccone,et al.  Trends and Characteristics of Young Non-Small Cell Lung Cancer Patients in the United States , 2015, Front. Oncol..

[26]  G. Mills,et al.  An Integrated Molecular Analysis of Lung Adenocarcinomas Identifies Potential Therapeutic Targets among TTF1-Negative Tumors, Including DNA Repair Proteins and Nrf2 , 2015, Clinical Cancer Research.

[27]  M. Barton,et al.  Evidence-based estimates of the demand for radiotherapy. , 2015, Clinical oncology (Royal College of Radiologists (Great Britain)).

[28]  K. Khanna,et al.  Targeting homologous recombination, new pre-clinical and clinical therapeutic combinations inhibiting RAD51. , 2015, Cancer treatment reviews.

[29]  Q. You,et al.  Wogonin reverses multi-drug resistance of human myelogenous leukemia K562/A02 cells via downregulation of MRP1 expression by inhibiting Nrf2/ARE signaling pathway. , 2014, Biochemical pharmacology.

[30]  B. Chen,et al.  The catalytic subunit of DNA-dependent protein kinase is required for cellular resistance to oxidative stress independent of DNA double-strand break repair. , 2014, Free radical biology & medicine.

[31]  Hao Hu,et al.  DNA-PKcs is important for Akt activation and gemcitabine resistance in PANC-1 pancreatic cancer cells. , 2014, Biochemical and biophysical research communications.

[32]  S. Niture,et al.  Regulation of Nrf2-an update. , 2014, Free radical biology & medicine.

[33]  F. Xia,et al.  Ionizing radiation-induced DNA damage, response, and repair. , 2014, Antioxidants & redox signaling.

[34]  Jun Liang,et al.  Nrf2 is a potential therapeutic target in radioresistance in human cancer. , 2013, Critical reviews in oncology/hematology.

[35]  A. Levonen,et al.  The Keap1-Nrf2 pathway: Mechanisms of activation and dysregulation in cancer☆ , 2013, Redox biology.

[36]  Donna D. Zhang,et al.  Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism , 2011, Proceedings of the National Academy of Sciences.

[37]  Stephen G Swisher,et al.  Nrf2 and Keap1 Abnormalities in Non–Small Cell Lung Carcinoma and Association with Clinicopathologic Features , 2010, Clinical Cancer Research.

[38]  Donna D. Zhang,et al.  Nrf2 and p21 regulate the fine balance between life and death by controlling ROS levels , 2009, Cell cycle.

[39]  L. Wilson,et al.  Handbook of radiation oncology : basic principles and clinical protocols , 2009 .

[40]  S. Goodman,et al.  RNAi-mediated silencing of nuclear factor erythroid-2-related factor 2 gene expression in non-small cell lung cancer inhibits tumor growth and increases efficacy of chemotherapy. , 2008, Cancer research.

[41]  Shaomeng Wang,et al.  Targeting of AKT1 enhances radiation toxicity of human tumor cells by inhibiting DNA-PKcs-dependent DNA double-strand break repair , 2008, Molecular Cancer Therapeutics.

[42]  A. Nussler,et al.  Quercetin protects human hepatocytes from ethanol-derived oxidative stress by inducing heme oxygenase-1 via the MAPK/Nrf2 pathways. , 2007, Journal of hepatology.

[43]  I. Tannock,et al.  Repopulation of cancer cells during therapy: an important cause of treatment failure , 2005, Nature Reviews Cancer.

[44]  H. Stürzbecher,et al.  Homologous recombination and cell cycle checkpoints: Rad51 in tumour progression and therapy resistance. , 2003, Toxicology.

[45]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[46]  J. Nickoloff,et al.  Overexpression of human RAD51 and RAD52 reduces double-strand break-induced homologous recombination in mammalian cells. , 2001, Nucleic acids research.

[47]  S. Powell,et al.  DNA damage and repair following treatment with ionizing radiation. , 1990, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[48]  J. Ward,et al.  DNA damage produced by ionizing radiation in mammalian cells: identities, mechanisms of formation, and reparability. , 1988, Progress in nucleic acid research and molecular biology.

[49]  K J Johanson,et al.  Microelectrophoretic study of radiation-induced DNA damages in individual mammalian cells. , 1984, Biochemical and biophysical research communications.